Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01239121 · ClinicalTrials.gov registry record · NA
Regional Data Exchange to Improve Medication Safety
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 402
- Enrollment target
NCT01239121: Completed NA study, sponsored by VA Office of Research and Development.
NCT01239121 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 402 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01239121, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 402 participants
- Enrollment target
Study Summary
Medication reconciliation, a process by which a provider obtains and documents a thorough medication history with specific attention to comparing current and previous medication use, can prevent medication-related errors and harm. The aims of this study are: 1) To adapt medication reconciliation to include information from a computerized regional health information exchange (RHIO) in the Bronx, 2) To conduct a trial of the adapted medication reconciliation process and examine effects on medication errors, harm, and hospital costs, and 3) To identify factors that are barriers to adoption of the RHIO tool by James J. Peters (Bronx) VA providers. Findings from this project will provide an understanding of the effect of the RHIO tool on reducing harmful VA and non-VA medication use. It will also provide information on the feasibility of incorporating RHIO tool use into every day work flow for pharmacists and physicians.
Interventions
- OTHER HIE-Enhanced Medication Reconciliation
- OTHER Optimal Medication Reconciliation without HIE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 402 participants |
| Start Date | 2012-02 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01239121
The ClinicalTrials.gov registry entry for NCT01239121 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 402 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HIE-Enhanced Medication Reconciliation is the first listed.
NCT01239121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01239121 about?
NCT01239121 is a clinical study titled "Regional Data Exchange to Improve Medication Safety". Medication reconciliation, a process by which a provider obtains and documents a thorough medication history with specific attention to comparing current and previous medication use, can prevent medication-related errors and harm. The aims of this study are: 1) To adapt medication reconciliation to ...
What is the current status of trial NCT01239121?
This trial is currently completed. It is a NA study. The enrollment target is 402 participants. The study started on 2012-02. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01239121?
The interventions under investigation include: HIE-Enhanced Medication Reconciliation (OTHER), Optimal Medication Reconciliation without HIE (OTHER).
Who is sponsoring clinical trial NCT01239121?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.